S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Atrial natriuretic peptide clearance receptor agonist lowers pulmonary pressure in hypoxic rats.
TL;DR: The results suggest that the endogenous ANP may modulate pulmonary vascular tone in rats with hypoxic pulmonary hypertension.
Journal ArticleDOI
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
Deepak L. Bhatt,Muthiah Vaduganathan,David E. Kandzari,Martin B. Leon,Krishna J. Rocha-Singh,Raymond R. Townsend,Barry T. Katzen,Suzanne Oparil,Sandeep S. Brar,Vanessa DeBruin,Martin Fahy,George L. Bakris,Sidney Cohen,Ralph A D'Agostino,Murray D. Esler,John M. Flack,B.B. Katzen,Laura Mauri,Manuela Negoita,Ziad A. Abbud,Tayo Addo,David E. Anderson,John S. Angle,Herbert D. Aronow,Anvar Babaev,Keith H. Benzuly,Somjot S Brar,David Brown,D Calhoun,P A Casale,Sheldon Chaffer,James W. Choi,Eugene Chung,Debbie L. Cohen,Mark A. Creager,George Dangas,Harold L. Dauerman,Shukri David,Mark Davies,Eduardo de Marchena,Ali E. Denktas,Chandan Devireddy,William E. Downey,Mark E. Dunlap,D. Charles Fisher,Magdi Ghali,Eric Gnall,Raghava R. Gollapudi,Mark Goodwin,Nilesh J. Goswami,Luis Gruberg,Rajiv Gulati,Anuj Gupta,Anjan Gupta,Hitinder S. Gurm,Jeffrey W. Hastings,Scott Kinlay,Robert Kipperman,Maurice Buchbinder,Ajay J. Kirtane,Richard Kovach,David P. Lee,Samuel G. Mann,Steven P. Marso,Fadi Youssef Matar,E. M. Mazzaferri,Farrel Mandelsohn,Issam Moussa,Timothy N Murphy,Sandeep Nathan,Brian H. Negus,Sahil A. Parikh,Manesh R. Patel,Kirikumar Patel,Basil M. Paulus,George Petrossian,Alex Fritz Powell,Jacek J. Preibisz,Florian Rader,Otelio S. Randall,Mahmood K. Razavi,J. Reilly,Jonathan S. Reiner,Michael Ring,Mark Robbins,Kevin L. Rogers,N. Ruggiero,Renato M. Santos,William Wyatt Little,John Schindler,T. Scott,Thomas M. Shimshak,Mehdi H. Shishehbor,Mitchell Silver,Jasvindar Singh,K. Singh,David P. Slovut,Rick G Stoufer,Paul Teirsten,Thomas M. Todoran,George W. Vetrovec,Ron Waksman,Yale Wang,Sergio Waxman,R. C. Wilkins,Khaled M. Ziada,Frank J. Zidar +106 more
TL;DR: The SYMPLICITY HTN-3 trial showed the safety but not efficacy of the Symplicity system at 6 months follow-up in patients with treatment-resistant hypertension, and long-term blood pressure changes in renal artery denervation and sham control groups are reported.
Journal ArticleDOI
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers.
TL;DR: From the beginning of the pandemic hypertension appeared as one of the most common comorbidities in patients hospitalised with a Covid-19 infection as discussed by the authors, and was the most commonly associated with chronic lung cancer.
Journal ArticleDOI
Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice
Veronica Franco,Yiu-Fai Chen,Ji A Feng,Peng Li,Dajun Wang,Erum Hasan,Suzanne Oparil,Gilbert J. Perry,Gilbert J. Perry +8 more
TL;DR: Eplerenone prevents adverse cardiac remodelling related to pressure overload in ANP‐deficient mice, mainly due to an antifibrotic effect.
Journal ArticleDOI
Ovarian hormones and vascular disease.
Fadi G. Hage,Suzanne Oparil +1 more
TL;DR: The vasoprotective effects of estrogen are age-dependent and disappear with aging and/or estrogen deprivation, which may lead to innovative approaches to improving women's cardiovascular health.